Ligand-directed labelling strategies  are a newly developed way to attach a fluorescent tag to a GPCR

Drug discovery is shifting towards the development of biased ligands, which promote the engagement of differences in the chemokine systems between species which, in some cases, hampers the pre-clinical development

Encouraging Phase 1 results and supportive preclinical package assist in the launch of Phase 2 clinical development

Because Tag-lite® is based on FRET, we have collaborated with BMG Labtech to develop an application note

design for specific targets:  Not all targets have available high-affinity radioligands, but with the development

However, the drug development of CX3CR1 is hampered partially by the lack of structural information.

"We are an experienced, innovative, global team on a bold mission to improve health by creating and developing

protein-coupled receptors helps in elucidating the metabolic pathways involved in metabolic dysfunction and in developing

Recently, AlphaFold2 has been developed to predict structure models of many functionally important proteins

One potential solution is to develop analgesics that act at targets other than opioid receptors.

findings provide new insight into how EBI2 is activated by an oxysterol ligand and will facilitate the development

pharmacologists misinterpret how an antagonist interacts with its receptor, the consequences ripple across assay development

The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing

Here we developed and validated a label-free, liquid chromatography-mass spectrometry (LC-MS) based cell

(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel

- and ligand specific aGPCR functions using unique tools, and thus establishes a foundation for the development

pathological expression profile of GPR84 and, in the absence of direct structural information, recent developments

, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development

Through developing a high-resolution method, Hao Chen et al. directly visualized the fusion of vesicles Therefore, their comprehension is essential for developing new treatments for these disorders and advancing

Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Engineering NEW Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development

capacity of microglia to synthesize, degrade, and respond to cannabinoids which has implications for the development

As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation

Jon Wigginton will provide scientific expertise to support the company’s research and clinical development

The identification of unified innate threat pathways may provide insights into developing therapeutic

Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological

(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel

Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Antibody Engineering Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development

understand how aGPCR works but might also provide a guide to how pharmacological approaches will be developed among the aGPCR community, added to the fact that this will all take place for the first time in a developing

So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and

(Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization